NCT06630260 2026-01-215G-RUBYInstitute of Cancer Research, United KingdomPhase 1/2 Recruiting182 enrolled
NCT03287271 2024-08-12ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAKUniversity of California, San DiegoPhase 1/2 Recruiting90 enrolled